Quest Diagnostics ( $DGX) and the Case for a $260 Price Target (Check any stock’s price target on Tickeron.) The selected price target is $260 per share, roughly 10% above Quest Diagnostics' recent close near $236. The strongest bullish factors include solid organic revenue growth, expansion in high-value advanced diagnostics, and an active acquisition strategy. The biggest risks are potential reimbursement pressure, a richer valuation, and execution risk tied to M&A integration. $LH $SYK $MDT $ABT $SNN